MIGRANADE, INC. develops, manufactures, and markets homeopathic treatment medicines (tablets) for the treatment and prevention of acute migraine headaches for people of different age groups in the United States. The company is based in the greater Los Angeles, California.

Research & Development

Dr. Charles B. Hensley has put forth the theory that migraine headache is consequence of the depletion of trigeminal and associated neuronal intracellular levels of specific GSH as a result of an acute inhibition of the transport of cysteine via the EAAT3 transport system.